Page last updated: 2024-09-03

acetylphenylalanyl-prolyl-boroarginine and refludan

acetylphenylalanyl-prolyl-boroarginine has been researched along with refludan in 1 studies

Compound Research Comparison

Studies
(acetylphenylalanyl-prolyl-boroarginine)
Trials
(acetylphenylalanyl-prolyl-boroarginine)
Recent Studies (post-2010)
(acetylphenylalanyl-prolyl-boroarginine)
Studies
(refludan)
Trials
(refludan)
Recent Studies (post-2010) (refludan)
30003682754

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Callas, D; Fareed, J; Hoppensteadt, D; Kaiser, B; Mallinowska, K1

Other Studies

1 other study(ies) available for acetylphenylalanyl-prolyl-boroarginine and refludan

ArticleYear
Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems.
    Thrombosis research, 1994, Mar-01, Volume: 73, Issue:5

    Topics: Amino Acid Sequence; Antithrombin III; Boron Compounds; Cell-Free System; Enzyme Activation; Factor Xa; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Molecular Sequence Data; Molecular Weight; Oligopeptides; Recombinant Proteins; Thrombin

1994